Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials
Objective: To evaluate possible differences between brain dopamine transporter (DAT) binding in a group of symptomatic parkinsonism patients without dopaminergic degeneration and healthy individuals. Background: Dopaminergic neuroimaging studies of Parkinson’s disease (PD) have often used control gr...
Main Authors: | Emma A. Honkanen, Mikael Eklund, Simo Nuuttila, Tommi Noponen, Elina Jaakkola, Elina Mäkinen, Risto Hirvilammi, Marko Seppänen, Kari Lindholm, Filip Scheperjans, Riitta Parkkola, Juho Joutsa, Andrea Varrone, Valtteri Kaasinen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158221002515 |
Similar Items
-
Sex correction improves the accuracy of clinical dopamine transporter imaging
by: Emma A. Honkanen, et al.
Published: (2021-08-01) -
Akinetic Crisis in Parkinson's Disease Is Associated with a Severe Loss of Striatal Dopamine Transporter Function: A Report of Two Cases
by: Valtteri Kaasinen, et al.
Published: (2014-11-01) -
Parallel Appearance of Compulsive Behaviors and Artistic Creativity in Parkinson’s Disease
by: Juho Joutsa, et al.
Published: (2012-05-01) -
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
by: Samuli Arvola, et al.
Published: (2019-01-01) -
Utility of SPECT Functional Neuroimaging of Pain
by: Mohammed Bermo, et al.
Published: (2021-07-01)